- •Foreword
- •Preface
- •Contents
- •1.1 Introduction
- •1.2 Method
- •1.2.1 Databases
- •1.2.2 Dates
- •1.2.3 Keywords
- •1.2.4 Criteria for Inclusion
- •1.2.5 Criteria for Exclusion
- •1.2.6 Selection of Papers
- •1.3 Results
- •1.3.1 Subspecialty
- •1.3.2 Type of Telemedicine
- •1.3.3 Study Design
- •1.3.4 Final Conclusions of Papers
- •1.4 Discussion
- •References
- •2.1 Introduction
- •2.2 The Need for Diabetic Retinopathy Screening Programs
- •2.4 Guidelines for Referring Patients
- •2.7 Program Models for Diabetic Retinopathy Screening
- •2.9 Program Personnel and Operations
- •2.9.1 Primary Care Providers
- •2.9.2 Photographers
- •2.9.3 Clinical Consultants
- •2.9.4 Administrators
- •2.9.5 A Note to CEOs, Operations Directors, and Clinic Managers
- •2.10 Policies and Procedures
- •2.10.1 Sample Protocol 1
- •2.10.1.1 Diabetic Retinopathy Screening Services
- •Policy
- •Background
- •Procedure
- •2.10.2 Sample Protocol 2
- •2.10.2.1 Pupil Dilation Before Diabetic Retinopathy Photography
- •Policy
- •Background
- •Procedure
- •2.10.3 Sample Protocol 3
- •2.10.3.1 Diabetic Retinopathy Photography Review
- •Policy
- •Background
- •Procedure
- •2.11 Technical Requirements
- •2.11.1 Connectivity
- •2.11.2 Resolution
- •2.11.3 Color
- •2.11.4 Stereopsis
- •2.11.5 Compression
- •2.11.6 Enhancement
- •2.11.7 Pupil Dilation
- •2.11.8 Early California Telemedicine Initiatives Diabetic Retinopathy Screening
- •2.11.9 The American Indian Diabetes Teleophthalmology Grant Program
- •2.11.10 Central Valley EyePACS Diabetic Retinopathy Screening Project
- •2.12.1 Diabetic Retinopathy
- •2.12.1.1 ADA Guidelines Terms
- •2.12.1.2 Vitrectomy
- •References
- •3: Stereopsis and Teleophthalmology
- •3.1 Introduction
- •3.2 History of Stereopsis and Stereopsis in Ophthalmology
- •3.3 Technology and Photography
- •3.3.3 Imaging Fields
- •3.3.4 Image Viewing Techniques
- •3.3.5 Image Compression
- •3.4 Stereoscopic Teleophthalmology Systems
- •3.4.1 University of Alberta
- •3.4.4 Joslin Vision Network
- •3.5 Conclusion
- •References
- •4.1 Introduction
- •4.2 Methods
- •4.2.1 Main Outcome Measures
- •4.3 Results
- •4.3.1 Retinal Video Recording Versus Retinal Still Photography
- •4.3.2 Video Compression Analysis
- •4.4 Discussion
- •References
- •5.1 Introduction
- •5.1.1 Automated, Remote Image Analysis of Retinal Diseases
- •5.1.2 Telehealth
- •5.2 Design Requirements
- •5.2.1 Telehealth Network Architecture
- •5.2.2 Work Flow
- •5.2.3 Performance Evaluation of the Network
- •5.3 Automated Image Analysis Overview
- •5.3.1 Quality Assessment Module
- •5.3.2 Vascular Tree Segmentation
- •5.3.3 Quality Evaluation
- •5.4 Anatomic Structure Segmentation
- •5.4.1 Optic Nerve Detection
- •5.4.2 Macula
- •5.4.3 Lesion Segmentation
- •5.4.4 Lesion Population Description
- •5.4.5 Image Query
- •5.5 Summary
- •References
- •6.1 Introduction
- •6.3 Optical Coherence Tomography to Detect Leakage
- •References
- •7.1 Introduction
- •7.2 Patients and Methods
- •7.2.1 Participants
- •7.2.2 Methods
- •7.2.3 Statistics
- •7.3 Results
- •7.3.1 Reliability of Image Evaluation
- •7.3.2 Prevalence of Glaucomatous Optic Nerve Atrophy
- •7.4 Discussion
- •7.5 Perspectives
- •References
- •8.1 Introduction
- •8.1.2 Homology Between Retinal and Systemic Microvasculature
- •8.1.3 Need for More Precise CVD Risk Prediction
- •8.2.1 Retinal Microvascular Signs
- •8.2.2 Retinal Vessel Biometry
- •8.2.3 Newer Retinal Imaging for Morphologic Features of Retinal Vasculature
- •8.3 Associations of Retinal Imaging and CVD Risk
- •8.3.1.1 Risk of Pre-clinical CVD
- •8.3.1.2 Risk of Stroke
- •8.3.1.3 Risk of Coronary Heart Disease
- •8.3.2.1 Risk of Hypertension
- •8.3.2.2 Risk of Stroke
- •8.3.2.3 Risk of Coronary Heart Disease
- •8.3.2.4 Risk of Peripheral Artery Disease
- •8.3.3 Newer Morphologic Features of Retinal Vasculature
- •8.4 Retinal Imaging and Its Potential as a Tool for CVD Risk Prediction
- •References
- •9.1 Alzheimer’s Disease
- •9.2 Treatments
- •9.3 Diagnosis
- •9.6 Conclusions
- •References
- •10.1 Introduction
- •10.1.1 Stroke
- •10.1.2 Heart Disease
- •10.1.3 Arteriovenous Ratio
- •10.2 Purpose
- •10.3 Method
- •10.3.1 Medical Approach
- •10.3.2 Technical Approach
- •10.3.3 Output of Medical Data
- •10.4 Patients
- •10.5 Results
- •10.5.1 Medical History
- •10.5.2 Telemedical Evaluation of Retinal Vessels
- •10.5.2.1 Prevalence of Retinal Microangiopathy
- •10.5.2.2 Arteriovenous Ratio
- •10.5.2.3 PROCAM-Index
- •10.6 Discussion and Perceptive
- •10.6.1 Estimation of “Stroke Risk” Estimated by the Stage of Retinal Microangiopathy
- •References
- •11.1 Introduction
- •11.2 System Requirements
- •11.3 Fundus Camera
- •11.4 Imaging Procedure
- •11.4.1 Reading Center Procedure
- •11.5 Detection of Macular Edema
- •11.6 Implementation
- •11.7 Unreadable Images
- •11.7.1 Impact on Overall Diabetic Retinopathy Assessment Rates
- •11.7.2 Compliance with Recommendations
- •11.7.3 Challenges
- •11.7.4 Summary
- •References
- •12.1 Screening
- •12.2 Background
- •12.3 Historical Perspective in England
- •12.4 Methodology
- •12.4.1 The Aim of the Programme
- •12.5 Systematic DR Screening
- •12.6 Cameras for Use in the English Screening Programme
- •12.7 Software for Use in the English Screening Programme
- •12.9 Implementation in England
- •12.11 Quality Assurance
- •12.12 The Development of External Quality Assurance in the English Screening Programme
- •12.13 Information Technology (IT) Developments for the English Screening Programme
- •12.14 Dataset Development
- •12.15 The Development of External Quality Assurance Test Set for the English Screening Programme
- •12.16 Failsafe
- •12.17 The Epidemic of Diabetes
- •References
- •13.1 Introduction
- •13.2 Burden of Diabetes and Diabetic Retinopathy in India
- •13.3 Diabetic Retinopathy Screening Models
- •13.4 Need for Telescreening
- •13.5 Guidelines for Telescreening
- •13.6 ATA Categories of DR Telescreening Validation
- •13.7 Yield of Diabetic Retinopathy in a Telescreening Model
- •13.8 How Are Images Transferred
- •13.10 How Many Fields Are Enough for Diabetic Retinopathy Screening
- •13.11 Is Mydriasis Needed While Using Nonmydriatic Camera?
- •13.12 Validation Studies on Telescreening
- •13.12.1 Accuracy of Telescreening
- •13.12.2 Patient Satisfaction in Telescreening
- •13.12.3 Cost Effectivity
- •13.12.4 Telescreening for Diabetic Retinopathy: Our Experience
- •13.13 Future of Diabetic Retinopathy Screening
- •References
- •14.1 Introduction
- •14.2 Methods
- •14.3 Discussion
- •14.4 Conclusion
- •References
- •15.1 Introduction
- •15.1.1 Description of the EADRSI
- •15.5 State Support of Screening in the Safety Net
- •15.7 Screening Economics for Providers
- •15.8 Patient Sensitivity to Fees
- •15.9 Conclusion
- •References
- •16.1 Introduction
- •16.2 Setting Up the New Screening Model
- •16.2.1 Phase 1: Training
- •16.2.2 Phase 2: Evaluation of Agreement
- •16.2.3 Phase 3: Implementation of the Screening Model
- •16.3 Technologic Requirements
- •16.3.1 Data Management
- •16.3.2 Data Models
- •16.3.2.1 Data Scheme for Patient-Related Information
- •16.3.2.2 Data Scheme for Images
- •Fundus Camera VISUCAM Pro NM
- •PACS Server
- •ClearCanvas DICOM Visualizer
- •16.4 Results
- •16.4.1 Phase 2: Agreement Evaluation
- •16.4.2 Phase 3: Implementation of the Screening Model
- •16.5 Discussion
- •16.5.1 Evaluation of the Screening Model
- •16.5.2 Prevalence of DR
- •16.5.3 Quality Evaluation
- •16.6 Conclusion
- •References
- •17.1.3 Examination and Treatment
- •17.1.4 Limitations of Current Care
- •17.2 Telemedicine and ROP
- •17.2.2 Accuracy and Reliability of Telemedicine for ROP Diagnosis
- •17.2.3 Operational ROP Telemedicine Systems
- •17.2.4 Potential Barriers
- •17.3 Closing Remarks
- •17.3.1 Future Directions
- •References
- •18.1 Introduction
- •18.2 Neonatal Stress and Pain
- •18.3 ROP Screening Technique
- •18.4 Effect of Different Examination Techniques on Stress
- •18.5 Future of Retinal Imaging in Babies
- •References
- •19.1 Introduction
- •19.2 History of the Program
- •19.3 Telehealth Technologies
- •19.4 Impact of the Program
- •Selected References
- •Preamble
- •Introduction
- •Background
- •The Diabetic Retinopathy Study (DRS)
- •Mission
- •Vision
- •Goals
- •Guiding Principles
- •Ethics
- •Clinical Validation
- •Category 1
- •Category 2
- •Category 3
- •Category 4
- •Communication
- •Medical Care Supervision
- •Patient Care Coordinator
- •Image Acquisition
- •Image Review and Evaluation
- •Information Systems
- •Interoperability
- •Image Acquisition
- •Compression
- •Data Communication and Transmission
- •Computer Display
- •Archiving and Retrieval
- •Security
- •Reliability and Redundancy
- •Documentation
- •Image Analysis
- •Legal Requirements
- •Facility Accreditation
- •Privileging and Credentialing
- •Stark Act and Self-referrals
- •State Medical Practice Acts/Licensure
- •Tort Liability
- •Duty
- •Standards of Care
- •Consent
- •Quality Control
- •Operations
- •Customer Support
- •Originating Site
- •Transmission
- •Distant Site
- •Financial Factors
- •Reimbursement
- •Grants
- •Federal Programs
- •Other Financial Factors
- •Equipment Cost
- •Summary
- •Abbreviations
- •Appendices
- •Appendix A: Interoperability
- •Appendix B: DICOM Metadata
- •Appendix C: Computer-Aided Detection
- •Appendix D: Health Insurance Portability and Accountability Act (HIPAA)
- •Appendix F: Quality Control
- •Appendix H: Customer Support
- •Level 1
- •Level 2
- •Level 3
- •Appendix I: Reimbursement
- •Medicare
- •Medicaid
- •Commercial Insurance Carrier Reimbursement
- •Other Financial Factors
- •Disease Prevention
- •Resource Utilization
- •American Telemedicine Association’s Telehealth Practice Recommendations for Diabetic Retinopathy
- •Conclusion
- •References
- •Contributors
- •Second Edition
- •First Edition
- •Index
Appendix |
203 |
|
|
size and resolution. Displays should be calibrated regularly to ensure Þdelity with original validation display conditions. Revalidation should be performed if settings are changed. Ambient light level, reßections, and other artifacts should be controlled to ensure standardized viewing.
lar to using hardcopy retinal imaging studies and medical records. Policies and procedures should include internal redundancy systems, backup telecommunications, and a disaster plan. Digital retinal images and reports should be retained as part of patient medical records to meet regulatory, facility, and medical staff clinical needs.
Archiving and Retrieval
Ocular telehealth systems should provide storage capacities in compliance with facility, state, and federal medical record retention regulations. Images may be stored at imaging or reading sites, or offsite, and must satisfy all jurisdiction requirements. Past images and reports should be available.
Each facility should have digital image archiving policies and procedures equivalent to existing policies for protecting other data and hardcopy records. Telehealth programs should also address Health Insurance Portability and Accountability Act (HIPAA) security requirements for data archive and disaster recovery.
Documentation
Readers rendering reports on DR level or other ocular abnormalities should comply with standardized diagnostic and management guidelines as established by the American Academy of Ophthalmology [74, 75] or the American Optometric Association [76]. Reports should be based on HL7 and DICOM standards software forms and meets interoperability standards. Forms should allow ocular Þndings be recorded to accepted standards of deÞned DR levels. Medical nomenclature should conform to SNOMED CT¨ standards. Transmission of reports should conform to HIPAA privacy and security requirements.
Security |
Image Analysis |
Ocular telehealth systems should have network and software security protocols to protect patient conÞdentiality and identiÞcation of image data. Measures should be taken to safeguard and ensure data integrity against intentional or unintentional data corruption. Privacy should be ensured through a minimum 128-bit encryption and two-factor authentication technology. Digital signatures may be used at image acquisition sites. Transmission of retinal imaging studies and study results should conform to HIPAA requirements.
Computer algorithms to enhance digital retinal image quality or provide automated identiÞcation of retinal pathology are emerging technologies. Image analysis tools for enhancing image quality (i.e., histogram equalization, edge sharpening, image deconvolution) or identifying lesions such as hemorrhages or hard exudates can be used to aid retinopathy assessment. Image processing algorithms should undergo rigorous clinical validation. Appendix C summarizes computer-aided detection of DR research and development.
Legal Requirements
Reliability and Redundancy
Written policies and procedures should be in place to ensure continuity of care at levels simi-
Legal and regulatory issues relating to the practice of ocular telehealth are generally the same as other telemedicine modalities and carry the risk
204 |
Appendix |
|
|
management considerations of conventional medical practice [59, 77, 78]. A DR telehealth program should use the same safeguards to mitigate risk.
Facility Accreditation
Some hospital telehealth programs fall within regulatory jurisdictions of the Joint Commission (JC) and/or Centers for Medicare and Medicaid Services [66]. The JC and Accreditation Association for Ambulatory Health Care (AAAHC) accredit ambulatory healthcare [66]. Previous and current JC standards indicate accrediting bodies cover telemedicine activities, making regulatory compliance a mandatory component for most hospital-based telehealth programs. There are speciÞc references to telemedicine in JC Environment of Care and Medical Staff sections. CMS and AAAHC requirements occur indirectly through related activities, for example, standards for contract care.
Health Insurance Portability
and Accountability Act (HIPAA)
Ocular telehealth programs should obtain professional consultation for HIPAA compliance speciÞc to their program. Telehealth programs should consider HIPAA privacy [79] and security [80] regulations in clinical, administrative, and technical operation plans. Privacy and security issues are detailed in Appendix D.
Privileging and Credentialing
Telehealth providers may require formal privileging and credentialing. Providers responsible for interpretation of retinal telehealth images should be credentialed and obtain privileges at originating and distant sites if required by applicable statues, regulations, and facility bylaws [81, 82]. See Appendix E for alternatives per JC guidelines.
Stark Act and Self-referrals
Some telemedicine risks are more problematic than others (e.g., antitrust, fraud and abuse, kickbacks, and self-referrals). Self-referrals occur when physicians refer patients to medical facilities in which they have a Þnancial interest. For example, an ophthalmologist places a retinal imaging workstation in a primary care providerÕs ofÞce at deep discount or gratis and reads images at little or no charge. The ÒantikickbackÓ Stark statute may have been violated if patients needing laser treatment are referred to the ophthalmologist. This may be prevented by charging the primary care provider full market value for equipment and services and offering the patient a choice of referral ophthalmologists for treatment.
State Medical Practice Acts/Licensure
Many telehealth legal issues assume telemedicine is the practice of medicine. These issues are addressed variably by state medical practice acts, but even in the absence of speciÞc statutory or regulatory deÞnitions, telehealth legal claims would be difÞcult to defend against otherwise [59]. All states require licensure for rendering medical care to patients located in the state. It could be argued that, with telemedicine, the remote patient ÒvisitsÓ the physician in the physicianÕs state. However, for practical purposes, a physician is considered subject also to the medical practice laws and regulations where the patient is located [83].
Some states are permissive regarding telemedicine service from physicians residing outside the state while other states provide a special Òtelemedicine license.Ó Many states are amending medical practice acts to speciÞcally address telemedicine. More than half require full and unrestricted licensure to render care by telemedicine to a patient residing in the state.
DR telehealth providers should carefully examine telemedicine rules in the states of intended practice. Licensure summaries are provided by the American Medical Association and
